CervoMed to Present at the 2023 Roth Healthcare Opportunities Conference
BOSTON, Oct. 5, 2023 /PRNewswire/ — CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced it will participate in the 2023 Roth Healthcare Opportunities Conference on Thursday, October 12, 2023 in New York. Members of the Company’s senior management team will be presenting and hosting 1×1 meetings at the conference.
Related news for (CRVO)
- CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod’s Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration
- Today’s Top Performers: MoBot’s Market Review 07/28/25 07:00 AM
- 24/7 Market News Snapshot 28 July, 2025 – CervoMed Inc. Common Stock (NASDAQ:CRVO)
- CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
- CervoMed Reports First Quarter 2025 Financial Results and Provides Corporate Updates